{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T19:00:48Z","timestamp":1780167648239,"version":"3.54.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,30]]},"DOI":"10.7759\/cureus.109938","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:12:16Z","timestamp":1780164736000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Peripartum Cardiomyopathy With Complete Functional Recovery: The Role of Multimodality Imaging and Optimized Medical Therapy"],"prefix":"10.7759","author":[{"given":"Cesar","family":"Baltodano Dangla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Kaleb","family":"Romero R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Cristobal","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Canales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enamaria","family":"Villalta Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania M","family":"Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Jeovany","family":"Urbina Malia\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Larios Alem\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasson E","family":"Rostran Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston S","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sa\u00e9nz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs J","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P, et al.. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019, 21:827-43. 10.1002\/ejhf.1493","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner D","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, et al.. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007, 128:589-600. 10.1016\/j.cell.2006.12.036","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum cardiomyopathy: JACC state-of-the-art review","volume":"75","author":"Davis MB","year":"2020","unstructured":"Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:207-21. 10.1016\/j.jacc.2019.11.014","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs070","article-title":"Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy","volume":"14","author":"Biteker M","year":"2012","unstructured":"Biteker M, Ilhan E, Biteker G, Duman D, Bozkurt B. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail. 2012, 14:895-901. 10.1093\/eurjhf\/hfs070","journal-title":"Eur J Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy)","volume":"66","author":"McNamara DM","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R, et al.. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy). J Am Coll Cardiol. 2015, 66:905-14. 10.1016\/j.jacc.2015.06.1309","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005472","article-title":"Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy","volume":"6","author":"Schelbert EB","year":"2017","unstructured":"Schelbert EB, Elkayam U, Cooper LT, et al.. Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy. J Am Heart Assoc. 2017, 6:10.1161\/JAHA.117.005472","journal-title":"J Am Heart Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/echo.15071","article-title":"Persistence of abnormal global longitudinal strain in women with peripartum cardiomyopathy","volume":"38","author":"Bortnick AE","year":"2021","unstructured":"Bortnick AE, Lama von Buchwald C, Hasani A, et al.. Persistence of abnormal global longitudinal strain in women with peripartum cardiomyopathy. Echocardiography. 2021, 38:885-91. 10.1111\/echo.15071","journal-title":"Echocardiography"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira MD","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, et al.. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002, 105:539-42. 10.1161\/hc0402.102975","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx428","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD","volume":"38","author":"Arrigo M","year":"2017","unstructured":"Arrigo M, Blet A, Mebazaa A. Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD. Eur Heart J. 2017, 38:2680-2. 10.1093\/eurheartj\/ehx428","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.717","article-title":"The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis","volume":"62","author":"Bello N","year":"2013","unstructured":"Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013, 62:1715-23. 10.1016\/j.jacc.2013.08.717","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2848","article-title":"Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","volume":"25","author":"Tsutsui H","year":"2023","unstructured":"Tsutsui H, Albert NM, Coats AJ, et al.. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail. 2023, 25:616-31. 10.1002\/ejhf.2848","journal-title":"Eur J Heart Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01808-z","article-title":"Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM)","volume":"110","author":"Hoevelmann J","year":"2021","unstructured":"Hoevelmann J, Muller E, Azibani F, et al.. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM). Clin Res Cardiol. 2021, 110:1259-69. 10.1007\/s00392-021-01808-z","journal-title":"Clin Res Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.03.052","article-title":"NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy","volume":"357","author":"Imran TF","year":"2022","unstructured":"Imran TF, Mohebali D, Lopez D, et al.. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy. Int J Cardiol. 2022, 357:48-54. 10.1016\/j.ijcard.2022.03.052","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2603","article-title":"A global perspective on the management and outcomes of peripartum cardiomyopathy: a\u00a0systematic review and meta-analysis","volume":"24","author":"Hoevelmann J","year":"2022","unstructured":"Hoevelmann J, Engel ME, Muller E, et al.. A global perspective on the management and outcomes of peripartum cardiomyopathy: a\u00a0systematic review and meta-analysis. Eur J Heart Fail. 2022, 24:1719-36. 10.1002\/ejhf.2603","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-1067-x","article-title":"Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging","volume":"18","author":"Mouquet F","year":"2008","unstructured":"Mouquet F, Lions C, de Groote P, et al.. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2008, 18:2765-9. 10.1007\/s00330-008-1067-x","journal-title":"Eur Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001062","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e876-94. 10.1161\/CIR.0000000000001062","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner D","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, et al.. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017, 38:2671-9. 10.1093\/eurheartj\/ehx355","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.04.043","article-title":"Long-term outcomes of women with peripartum cardiomyopathy having subsequent pregnancies","volume":"82","author":"Pachariyanon P","year":"2023","unstructured":"Pachariyanon P, Bogabathina H, Jaisingh K, Modi M, Modi K. Long-term outcomes of women with peripartum cardiomyopathy having subsequent pregnancies. J Am Coll Cardiol. 2023, 82:16-26. 10.1016\/j.jacc.2023.04.043","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463279-severe-peripartum-cardiomyopathy-with-complete-functional-recovery-the-role-of-multimodality-imaging-and-optimized-medical-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:12:16Z","timestamp":1780164736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463279-severe-peripartum-cardiomyopathy-with-complete-functional-recovery-the-role-of-multimodality-imaging-and-optimized-medical-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.109938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}